BACKGROUND: Despite evidence that CNS treatment is associated with cognitive and academic impairment, interventions to prevent or mitigate these problems are limited. The purpose was to determine if early intervention can prevent declines in mathematics abilities. PROCEDURES: Fifty-seven children with ALL were enrolled and randomized to a Mathematics Intervention or Standard Care. Subjects completed neurocognitive assessments prior to the intervention, post-intervention, and 1 year later. Parents received written results and recommendations for use with their school. The Mathematics Intervention was based on Multiple Representation Theory and delivered individually over 1 year. RESULTS:Thirty-two of 57 subjects completed the study and were included in data analyses. These 32 subjects completed all neurocognitive assessments and, for those in the Intervention Group, 40-50 hours of the Mathematics Intervention. There were no group differences on relevant demographic variables; risk stratification; number of intrathecal methotrexate injections; or high dose systemic methotrexate. Significant improvements in calculation and applied mathematics from Baseline to Post-Intervention (P = 0.003 and 0.002, respectively) and in visual working memory from Baseline to 1 year Follow-up (P = 0.02) were observed in the Intervention but not the Standard Care Group. Results from repeated measures ANOVA demonstrated significant between group differences for applied mathematics [F(2,29) = 12.47, P < 0.001] and visual working memory [F(2,29) = 5.53, P = 0.009]. CONCLUSIONS: The Mathematics Intervention improved mathematics abilities and visual working memory compared to standard care. Future studies are needed to translate the Mathematics Intervention into a "virtual" delivery method more readily available to parents and children.
RCT Entities:
BACKGROUND: Despite evidence that CNS treatment is associated with cognitive and academic impairment, interventions to prevent or mitigate these problems are limited. The purpose was to determine if early intervention can prevent declines in mathematics abilities. PROCEDURES: Fifty-seven children with ALL were enrolled and randomized to a Mathematics Intervention or Standard Care. Subjects completed neurocognitive assessments prior to the intervention, post-intervention, and 1 year later. Parents received written results and recommendations for use with their school. The Mathematics Intervention was based on Multiple Representation Theory and delivered individually over 1 year. RESULTS: Thirty-two of 57 subjects completed the study and were included in data analyses. These 32 subjects completed all neurocognitive assessments and, for those in the Intervention Group, 40-50 hours of the Mathematics Intervention. There were no group differences on relevant demographic variables; risk stratification; number of intrathecal methotrexate injections; or high dose systemic methotrexate. Significant improvements in calculation and applied mathematics from Baseline to Post-Intervention (P = 0.003 and 0.002, respectively) and in visual working memory from Baseline to 1 year Follow-up (P = 0.02) were observed in the Intervention but not the Standard Care Group. Results from repeated measures ANOVA demonstrated significant between group differences for applied mathematics [F(2,29) = 12.47, P < 0.001] and visual working memory [F(2,29) = 5.53, P = 0.009]. CONCLUSIONS: The Mathematics Intervention improved mathematics abilities and visual working memory compared to standard care. Future studies are needed to translate the Mathematics Intervention into a "virtual" delivery method more readily available to parents and children.
Authors: K D Cicerone; C Dahlberg; K Kalmar; D M Langenbahn; J F Malec; T F Bergquist; T Felicetti; J T Giacino; J P Harley; D E Harrington; J Herzog; S Kneipp; L Laatsch; P A Morse Journal: Arch Phys Med Rehabil Date: 2000-12 Impact factor: 3.966
Authors: I M Moore; K A Espy; P Kaufmann; J Kramer; K Kaemingk; P Miketova; N Mollova; M Kaspar; A Pasvogel; K Schram; W Wara; J Hutter; K Matthay Journal: Semin Oncol Nurs Date: 2000-11 Impact factor: 2.315
Authors: S J Thompson; L Leigh; R Christensen; X Xiong; L E Kun; R L Heideman; W E Reddick; A Gajjar; T Merchant; C H Pui; M M Hudson; R K Mulhern Journal: J Clin Oncol Date: 2001-03-15 Impact factor: 44.544
Authors: N von der Weid; I Mosimann; A Hirt; P Wacker; M Nenadov Beck; P Imbach; U Caflisch; F Niggli; A Feldges; H P Wagner Journal: Eur J Cancer Date: 2003-02 Impact factor: 9.162
Authors: Kevin R Krull; Deepa Bhojwani; Heather M Conklin; Deqing Pei; Cheng Cheng; Wilburn E Reddick; John T Sandlund; Ching-Hon Pui Journal: J Clin Oncol Date: 2013-05-06 Impact factor: 44.544
Authors: Lauren E Cox; Jason M Ashford; Kellie N Clark; Karen Martin-Elbahesh; Kristina K Hardy; Thomas E Merchant; Robert J Ogg; Sima Jeha; Victoria W Willard; Lu Huang; Hui Zhang; Heather M Conklin Journal: Neurooncol Pract Date: 2015-03-13
Authors: Jin-Shei Lai; Corey Bregman; Frank Zelko; Cindy Nowinski; David Cella; Jennifer J Beaumont; Stewart Goldman Journal: Qual Life Res Date: 2017-04-26 Impact factor: 4.147
Authors: Heather M Conklin; Jason M Ashford; Kellie N Clark; Karen Martin-Elbahesh; Kristina K Hardy; Thomas E Merchant; Robert J Ogg; Sima Jeha; Lu Huang; Hui Zhang Journal: J Pediatr Psychol Date: 2017-03-01
Authors: Matthew J Ehrhardt; Daniel A Mulrooney; Chenghong Li; Malek J Baassiri; Kari Bjornard; John T Sandlund; Tara M Brinkman; I-Chan Huang; Deo Kumar Srivastava; Kirsten K Ness; Leslie L Robison; Melissa M Hudson; Kevin R Krull Journal: Cancer Date: 2017-09-15 Impact factor: 6.860
Authors: Heather M Conklin; Robert J Ogg; Jason M Ashford; Matthew A Scoggins; Ping Zou; Kellie N Clark; Karen Martin-Elbahesh; Kristina K Hardy; Thomas E Merchant; Sima Jeha; Lu Huang; Hui Zhang Journal: J Clin Oncol Date: 2015-10-12 Impact factor: 44.544
Authors: Yin Ting Cheung; Noah D Sabin; Wilburn E Reddick; Deepa Bhojwani; Wei Liu; Tara M Brinkman; John O Glass; Scott N Hwang; Deokumar Srivastava; Ching-Hon Pui; Leslie L Robison; Melissa M Hudson; Kevin R Krull Journal: Lancet Haematol Date: 2016-09-14 Impact factor: 18.959